The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
South East; Berkshire; Buckinghamshire and Oxfordshire
Location of affected unit(s)
Oxford
Sector
Professional Services Scientific, Architectural And Engineering Technical Activities Scientific Research And Development 72.11 - Research and experimental development on biotechnology
100 jobs Number of planned job creations
Announcement Date
13 September 2018
Employment effect (start)
Foreseen end date
Description
Oxford BioMedica, a gene therapy business, has announced that it is to create 100 new jobs after signing a lease on new premises. The business has taken over a former Royal Mail sorting office on a 15 year lease and will tranform the site adding warehouse and laboratories. The jobs will be added over a two year period, with the first jobs expected to be filled when the warehouse and new offices are ready, which is expected to be sometime in the first quarter of 2019. When all the jobs are filled the headcount will be around 500 staff.
Sources
Citation
Eurofound (2018), Oxford BioMedica, Business expansion in United Kingdom, factsheet number 95519, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/95519.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
